CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers Dec 12, 2024 22:00 HKT/SGT Read More
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024 Dec 12, 2024 15:27 HKT/SGT Read More
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Dec 12, 2024 12:11 HKT/SGT Read More
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia Dec 11, 2024 13:45 HKT/SGT Read More
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections Dec 10, 2024 20:30 HKT/SGT Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 14:00 JST Read More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 13:00 HKT/SGT Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico Dec 05, 2024 10:22 HKT/SGT Read More
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day Dec 04, 2024 14:30 HKT/SGT Read More
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Dec 04, 2024 11:08 HKT/SGT Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 22:30 JST Read More
Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain Dec 02, 2024 22:08 HKT/SGT Read More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 21:30 HKT/SGT Read More
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Dec 02, 2024 10:34 HKT/SGT Read More